Design and synthesis of 225Ac radioimmunopharmaceuticals

Applied Radiation and Isotopes

Volumn 57, Issue 6, 2002, Pages 841-847

  McDevitt, Michael R ^a   Ma, Dangshe ^a   Simon, Jim ^b   Frank, R Keith ^b   Scheinberg, David A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b DOW CHEMICAL COMPANY   (United States)

Author keywords

225Ac; Alpha emitting radionuclide; In vivo generator; Monoclonal antibody; Radioimmunotherapy

Indexed keywords

ANTIBODIES; BONE; CHELATION; DISEASES; RADIOISOTOPES; RADIOTHERAPY;

RADIOIMMUNOTHERAPY;

DRUG PRODUCTS;

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; ACTINIUM; ACTINIUM 225; ASTATINE 211; BISMUTH 213; CHELATE; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; RADIUM 224; UNCLASSIFIED DRUG; RADIOPHARMACEUTICAL AGENT;

ALPHA RADIATION; ANKYLOSING SPONDYLITIS; ARTICLE; BONE; CHELATION; DRUG DESIGN; DRUG HALF LIFE; DRUG STABILITY; DRUG SYNTHESIS; DRUG TARGETING; GLIOMA; IMMUNOREACTIVITY; ISOTOPE LABELING; LEUKEMIA; MODEL; PRIORITY JOURNAL; RADIOCHEMISTRY; RADIOIMMUNOTHERAPY; TECHNIQUE; CHEMISTRY; SYNTHESIS;

ACTINIUM; ANTIBODIES, MONOCLONAL; RADIOIMMUNOTHERAPY; RADIOPHARMACEUTICALS;

EID: 0036882336     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8043(02)00167-7     Document Type: Article

References (21)

1. Davis I.A., Glowienka K.A., Boll R.A., Deal K.A., Brechbiel M.W., Stabin M., Bochsler P.N., Mirzadeh S., Kennel S.J. Comparison of actinium-225 chelates. tissue distribution and radiotoxicity Nucl. Med. Biol. 26:1999;581-589.
2. Deal K.A., Davis I.A., Mirzadeh S., Kennel S.J., Brechbiel M.W. Improved in vivo stability of actinium-225 macrocyclic complexes. J. Med. Chem. 42:1999;2988-2992.
3. Geerlings M.W., Kaspersen F.M., Apostolidis C., Van der Hout R. The feasibility of Ac-225 as a source of a-particles in radioimmunotherapy. Nucl. Med. Comm. 14:1993;121-125.
4. 213Bi-HuM195 (anti-CD33). Proc. Am. Soc. Clin. Oncol. 18:1999;7.
5. 225Ac immunoconjugates. Nucl. Med. Comm. 16:1995;468-476.
6. Kampen, W.U., Brenner, W., Prause, J., Czech, N., Zuhayra, M., Muhle, C., Henze, E., 2001. Quantification of bone metabolism before and after treatment of patients with ankylosing spondylitis with the alpha-emitter Ra-224. J. Nucl. Med. 42(5), 337P.
7. Kotz D. Alpha particle therapy poised to become new line of cancer treatment. J. Nucl. Med. 39(2):1998;17N-19N.
8. Humm J.L., Chin L.M. A model of cell inactivation by alpha-particle internal emitters. Radiat. Res. 134:1993;143-150.
9. Lambrecht R.M., Tomiyoshi K., Sekine T. Radionuclide generators. Radiochim. Acta. 77:1997;103-123.
10. McDevitt M.R., Sgouros G., Finn R.D., Humm J.L., Jurcic J.G., Larson S.M., Scheinberg D.A. Radioimmunotherapy with alpha-emitting radionuclides. Eur. J. Nucl. Med. 25(9):1998;1341-1351.
11. 213Bi generator system for therapeutic clinical applications. construction and operation Appl. Radiat. Isot. 50:1999;895-904.
12. 213Bi labeled antibody constructs for clinical use. J. Nucl. Med. 40(10):1999;1722-1727.
13. 213Bi]J591) for radioimmunotherapy of prostate cancer. Cancer Res. 60:2000;6095-6100.
14. McDevitt M.R., Ma D., Lai L.T., Simon J., Borchardt P., Frank R.K., Wu K., Pellegrini V., Curcio M.J., Miederer M., Bander N.H., Scheinberg D.A. Tumor therapy with targeted atomic nanogenerators. Science. 294:2001;1537-1540.
15. Mirzadeh S. Generator-produced alpha-emitters. Appl. Radiat. Isot. 49(4):1998;345-349.
16. Nikula T.N., Curcio M.J., Brechbiel M.W., Gansow O.A., Finn R.D., Scheinberg D.A. A Rapid, single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodies. Nucl. Med. Biol. 22(3):1995;387-390.
17. Nikula T.N., McDevitt M.R., Finn R.D., Wu C., Kozak R.W., Garmestani K., Brechbiel M.W., Curcio M.J., Pippin C.G., Tiffany-Jones L., Geerlings M.W. Sr., Apostolidis C., Molinet R., Gansow O.A., Scheinberg D.A. Alpha-emitting Bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies. bioactivity, toxicity, and chemistry J. Nucl. Med. 40:1999;166-176.
18. Tiepolt C., Gruning T., Franke W.G. Renaissance of Ra-224 treatment in ankylosing spondylitis. J. Nucl. Med. 42(5):2001;128P.
19. Wilbur D.S. Potential use of alpha emitting radionuclides in treatment of cancer. Antibody Immunoconjugate Radiopharm. 4:1991;85-97.
20. Zalutsky M.R., Bigner D.D. Radioimmunotherapy with α-particle emitting radioimmunoconjugates. Acta Oncol. 35(3):1996;373-379.
21. Zalutsky M.R., Vaidyanathan G. Astatine-211-labeled radiotherapeutics. an emerging approach to targeted alpha particle radiotherapy Curr. Pharm. Des. 6(14):2000;1433-1455.